An algorithm for medication in the treatment of Complex PTSD

Similar documents
Insomnia: Updates in Medical Management. Michael Newnam M.D.

PSYCHIATRY INTAKE FORM

Anxiolytic and Hypnotic drugs

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD

Appendix: Psychotropic Medication Reference Tables

Antidepressant Medication Therapy in Primary Care July 25, 2013

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

New Patient Questionnaire

SEDATIVE-HYPNOTIC AGENTS

Safe and Effective Medication Approaches for Anxiety and Insomnia

Mental Health Intake Form

11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3

Managing Insomnia Disorder A Review of the Research for Adults

Insomnia. Arturo Meade MD

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Mental Health Intake Form

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?

Primary Care Provider & Psychiatric Consultant Roles. PC/PCP Role Session Objectives. Working as a Team. Joseph Cerimele Anna Ratzliff

Psychiatric Consultant Role in Collaborative Care Sept 12, 2013

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Insomnia treatment. Sleep hygiene education sleep hygiene teaches good sleeping habits. This includes:

You May Be at Risk. You are taking one of the following sedative-hypnotic medications: Diazepam (Valium ) Estazolam. Flurazepam.

Sleep History Questionnaire

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis)

You May Be at Risk. You are taking one of the following sedative-hypnotic medications:

MO Medicaid Foster Care Drugs FY10-FY14

Sedative / Hypnotics

3/9/2017. A module within the 8 hour Responding to Crisis Course. Our purpose

Guide to Psychiatric Medications for Children and Adolescents

UPDATE ON THE OUTPATIENT TREATMENT OF PSYCHIATRIC DISORDERS Amanda J. Williams, MD Grayson & Associates Montgomery, AL

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Treatment of Anxiety Disorders Controlled Substance Workshop. Shonda Phelon MSN, FNP-BC, APMHNP-BC MNA Convention 2011

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Sleep Disorders: Assessment and Therapeutic Options

#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS

9/17/2015 DIAGNOSTIC PUZZLES LEARNING OBJECTIVES MENTAL ILLNESS MEDICAL COMORBIDITIES

Intro to Concurrent Disorders

Question #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA

Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS

Anxiety& Depression in Primary Care- a Pharmacology Primer. Lisa Deloris Slade, DNP, MSN, FNP-BC North Carolina NP Spring Symposium March 27, 2017

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

What is sleep? o Sleep is a body s rest cycle.

Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD

14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III

Insomnia Agents (Sherwood Employer Group)

APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC)

Anjali Ahn, MD Beth Israel Deaconess Medical Center May 1, 2015

3/24/2016 DISCLOSURE STATEMENT PHARMACIST OBJECTIVES OVERVIEW TECHNICIAN OBJECTIVES PREVALENCE OF INSOMNIA THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA

Insomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)

IDDT Fidelity Action Planning Guidelines

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms

Disclosure. Sleep Medications in Primary Care: How to choose, what to avoid

PSYCHOTROPIC MEDICATION AND THE WORKPLACE. Dr. Marty Ewer 295 Fullarton Road Parkside

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Psychiatric Distress in Chronic & Terminal Illness Barb Henry, ARNP, MSN

Delirium, Dementia, and Amnestic Disorders. Dr.Al-Azzam 1

Anxiolytic drugs. Anxiolytics: reduce anxiety. Sedatives: decrease activity, calming effect. Hypnotics: induce sleep

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

continuing education for pharmacists

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Comparison of Insomnia Treatments

Psychotropic Medication Use in Dementia

How to Manage Insomnia with and without medications

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling

Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview

Psychopharmacology Pt 2 Ronald J Diamond M.D. Rev Interaction between Genes and Experience

Caring for the Mind: Managing Depression and Anxiety. Highlights from 2017 ONS Congress

Medications and Children Disorders

Benzodiazepines: risks, benefits or dependence

Mixing and Matching: Layering Medications as Family Physicians

Cluster 1 Common Mental Health Problems (mild)

literature that drug combinations containing butalbital should not be used in treatment of chronic pain and are not appropriate for long term routine

Klonopin and trazodone interactions

14. Percent

SOUND ASLEEP: MEDICATIONS AND BEHAVIORAL STRATEGIES FOR OLDER ADULTS

Disclosure. Sleep Medications in Primary Care: How to choose, what to avoid

Sedative Hypnotics. Description

Treatment of Anxiety (without benzos)

mood treatment center.com brain art from Hope Street Mental Health Greeting cards (hopestreetcards.com.au)

Psychopharmacology of Sleep Disorders

NEW PATIENT INTAKE FORM

See Important Reminder at the end of this policy for important regulatory and legal information.

ANTIANXIETY DRUGS: BENZODIAZEPINES

Phenomenology. Epidemiology

Using Benzodiazepines in Primary Care

FAKE XANAX PILL KILLS

Disclosure. Sleep Medications in Primary Care

Sedative Hypnotics. Description

VA/DoD Clinical Practice Guideline for Management of Post Traumatic Stress. Core Module

Pain. Fear can keep the patient from going to the Drs at appropriate time

Transcription:

An algorithm for medication in the treatment of Complex PTSD Andreas Laddis, M.D. aladdis@gmail.com ESTD Conference Bern November 10, 2017

The purpose for the presentation Algorithm for medication: My stepwise reasoning about the order in which I choose kinds of medication to test. My reasoning for this simple algorithm is based on the following three assumptions: 1. Medication facilitates psychotherapy. 2. Need for medication changes from the acute phases to the intervals between crises. 3. All psychiatric drugs mitigate irrational emotions of Complex PTSD despite their names as antianxiety, antidepressant, antipsychotic or mood stabilizer.

Medication facilitates psychotherapy. Medication facilitates re-exposure to events that resemble past traumatic ones. Medication mitigates the intensity of unstoppable negative emotions (fear, anger and aggression, anxiety) for the purpose of learning ways to cope with such danger. Only novel learning experiences, usually with psychotherapy, may eventually remove the reasons for emotions of that intensity and tenacity.

The typical life course of Complex PTSD Engagement in experiments with intimacy in existing or new relationships (e.g., between parents and children, between best friends, lovers and lifemates). Intimacy consists of making commitments to jointly pursue each partner s long-term goals. Partners keep their commitment regardless of how each partner s needs may vary and even if one partner becomes unable to contribute. Disengagement Enduring personality changes Fear of closeness Cynicism about others benevolence or their own worth Certainty about others love is an illusion Engagement Crisis of trust Disorder Disengagement Enduring personality changes become consolidated

Two kinds of disorder Crisis of trust Anxious and depressive, intrusive rumination about others intentions and expectations Relentlessly testing others intentions. Flashbacks, depersonalization, hallucinations

Two kinds of moods Engagement Disengagement Lingering moods from having lost hope Crisis of trust Extreme and lasting moods during frustration with current crisis and faith in the world s benevolence Similar emotions (fear, anger, anxiety, depression) arise from different experiences and reasons in the two phases of Complex PTSD s life course

All psychiatric drugs mitigate irrational emotions All of them mitigate negative emotions of Complex PTSD (fear, anger and aggression, anxiety) There is no good medication for depression. All psychiatric drugs may lessen depression indirectly, by reducing irrational anxiety and the failure to function that it causes. In addition to their antianxiety action, antipsychotics and mood stabilizers repair the biochemistry of schizophrenia and manic-depressive illness.

Step 1 Use a quick acting antianxiety drug in repeated doses Benzodiazepines are most reliable. Clonazepam (Klonopin) Alprazolam (Xanax) Lorazepam (Ativan) Alternatives are hydroxyzine, clonidine. Antipsychotics are safer, if large doses are required. Quetiapine/Seroquel, Risperidone/Risperdal, Olanzapine/Zyprexa, Haloperidol/Haldol

Step 2 At the same time, during the acute phase, Initiate buspirone (Buspar) or an antidepressant. These take 1-4 weeks to become effective they are only modestly effective in only two thirds of cases they often have side-effects Gabapentin (Neurontin) is effective as a long-term antianxiety drug for a few patients. If and when they take effect, they are useful as persistently active medication, without the risk of habituation and addiction. They usually are insufficient for prevention of relapse to acute symptoms. It is necessary then to supplement them with quick-acting drugs. Often, it is necessary to add a sleeper

Step 3 and Step 4 If buspirone or the antidepressant prescribed at Step 2 fail to provide their modest effect without side-effects, it is indicated to try alternative antidepressants, one at a time, with good documentation of efficacy (take advantage of side-effects) In the intervals between crises, transition from giving quick-acting antianxiety drugs (especially benzodiazepines) routinely to giving them only as necessary.

Step 5 Finally, if Buspar and antidepressants fail, give consideration to routine, long-term use of antipsychotics and mood stabilizers. Antipsychotics are modestly effective, but their longterm toxicity makes them a last resort option. There is little evidence that mood stabilizers are useful for reduction of emotional intensity or impulsivity. Gabapentin may be an exception. Antipsychotics and mood stabilizers should not be continued without proof of measurable efficacy.

Clinicians may suffer illusions of medication s efficacy Medication was working but then it lost its efficacy. The medication effect is limited. The effect varies with good or bad turns of social events The patient stopped taking his medicine and got worse. He got worse and then neglected medication or threw it away

Hypnotics Addictive Non- benzodiazepine Zaleplon (Sonata) Zolpidem (Ambien) Eszopiclone (Lunesta) Benzodiazepine Quazepam (Doral) Flurazepam (Dalmane) Not addictive Antipsychotic Quetiapine (Seroquel) Antidepressant Amitriptyline (Elavil) Trazodone (Oleptro) Ramelteon (Rozerem) Mirtazapine (Remeron) Doxepin (Silenor) Estazolam (ProSom) Temazepam (Restoril) Triazolam (Halcion)

The algorithm 1 Begin with one or more quick-acting antianxiety agents. Choose a benzodiazepine, hydroxyzine, clonidine or prazosin, depending on urgency for relief, potential for abuse, sideeffects. Add an antipsychotic, if agitation/impulsivity is so great that it demands unsafe amounts of other quick-acting drugs. 2 Initiate an antidepressant and/or buspirone. Choice depends on side-effects and sidebenefits (neuropathic pain, smoking cessation, etc.) Add an antipsychotic, if agitation/impulsivity is so great that it demands unsafe amounts of other quick-acting drugs. 3 If initial antidepressant/buspirone fails, revisit options for replacement. 4 Change the schedule for quick-action drugs to as needed. Transition to as needed when gains from antidepressants/buspirone or hopefulness from psychotherapy create a baseline of steady modulation of negative emotions. Make use of quick-acting drugs conditional on good use of psychotherapy: require attention to social triggers of symptoms (deception, current or anticipated, about fidelity to promises and expectations) and require adherence to psychotherapy for resolution of the threat of betrayal. 5 Mood stabilizers and continuous use of antipsychotics are options to use reluctantly, with documentation of efficacy and much attention to toxicity, if frequent and dangerous agitation persists.